Willow vs Telos Rx: Oral GLP-1 with tracking vs compounded options
Willow vs Telos Rx is a comparison between a telehealth-first program built around an oral GLP-1 plus tracking and a clinician-prescribed compounded option for semaglutide and tirzepatide. Early verdict: choose Willow if you prioritize structured progress tracking and follow-up; choose Telos Rx if you prefer lower starting prices and access to compounded semaglutide or tirzepatide subject to clinician review.
Explore Willow program and tracking
How the two models differ at a glance
This comparison focuses on the most distinctive supported differences: delivery model and support, medication format and regulatory notes, pricing and starting cost, medication options, and enrollment limitations and approvals. All statements below reflect captured evidence and preserved qualifiers.
Delivery model and ongoing support
Willow positions itself as a telehealth-first weight management program that emphasizes progress tracking and follow-up consultations. The provider frames its offering as a structured weight management journey rather than a medication subscription and highlights a licensed telehealth team, progress tracking tools, and follow-up consultations. Telos Rx is presented as an online, clinician-reviewed prescribing service for compounded medications with a care team; its materials emphasize one care team for two medication options.
Medication format and regulatory notes
Willow advertises an oral GLP-1 program. The evidence notes that when compounded medications are offered they are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Telos Rx explicitly offers compounded semaglutide and tirzepatide and repeats that compounded medications are not FDA-approved and are prescribed only after review by a US-licensed provider. Both providers state treatment is available only when a licensed clinician determines it is medically appropriate.
Pricing and starting costs
The captured evidence records Willow with a starting price of 299 and a price detail listed as 299. Telos Rx reports semaglutide from as low as $99 per month and tirzepatide from as low as $139 per month, with multiple statements including semaglutide as low as $99 per month. Telos Rx also includes statements like Pay $0 if not approved and Cancel anytime, no penalties in the captured text. Willow’s captured notes flag higher monthly entry pricing for some plans as a con. Exact shipping, fees, membership or cancellation details for Willow were not verified on the captured page.
See Telos Rx pricing and options
Direct comparison table
| Criteria | Willow | Telos Rx |
|---|---|---|
| Primary model | Telehealth-first program with progress tracking and follow-up | Clinician-reviewed online prescribing for compounded medications |
| Medication format | Oral GLP-1 program | Compounded semaglutide and tirzepatide |
| Starting price | 299 | Semaglutide as low as $99 per month; tirzepatide as low as $139 per month |
| Support features | Licensed telehealth team; progress tracking tools; follow-up consultations | One care team for medication options; clinician review required |
| Regulatory note | Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are prescribed only after review by a US-licensed provider |
Medication choice and clinical matching
Telos Rx describes two molecule options: semaglutide acting on GLP-1 and tirzepatide acting on GLP-1 plus GIP, and states a US-licensed provider decides which is right for a patient. Willow’s materials emphasize converting GLP-1 efficacy into long-term outcomes through behavioral and follow-up support tied to its program. Neither source supplies efficacy or outcome guarantees; both note medical approval is required.
Start Willow enrollment and consult
Eligibility, terms, and captured limits
Telos Rx explicitly urges people to confirm eligibility, medication, total cost, renewal terms and state availability before enrollment and notes pricing, eligibility, pharmacy, state coverage and renewal terms may change. Willow notes treatment is available only when a licensed clinician determines it is medically appropriate and captured landing-page evidence for Willow was limited or not readable.
Learn more about Willow requirements
Bottom line and how to choose
Willow vs Telos Rx contrast a structured oral GLP-1 program with progress tracking against a clinician-prescribed compounded medication pathway with lower starting prices on compounded semaglutide and tirzepatide. Both require clinician review and both include regulatory notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
Choose Willow if you want a telehealth-first program focused on progress tracking, follow-up consultations, and a structured digital workflow rather than a simple medication subscription. Choose Telos Rx if you prioritize access to compounded semaglutide or tirzepatide with starting prices reported as low as $99 per month for semaglutide and $139 per month for tirzepatide and are willing to confirm eligibility, state availability, and plan details before enrolling.